367 Pharmacokinetic and immunologic data from a phase I study of the click chemistry-based therapy SQ3370 in advanced solid tumors and soft-tissue sarcoma provides proof-of-concept for the CAPAC platform
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2021-11-01
|
| Colección: | Journal for ImmunoTherapy of Cancer |